Repurposing tin mesoporphyrin as a novel immune checkpoint therapy in the treatment of cancer: A preclinical evaluation.

e15129Background: Unprecedented clinical outcomes have been achieved in a variety of cancers by targeting the immune checkpoint molecules PD-1 and CTLA-4. However, as a significant number of patien...